These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8819585)

  • 81. HIV drug resistance testing shows promise.
    Stephenson J
    JAMA; 1999 Jan; 281(4):309-10. PubMed ID: 9929067
    [No Abstract]   [Full Text] [Related]  

  • 82. 4th International Workshop on HIV Drug Resistance and Treatment Strategies. Sitges, Spain, 12-16 June 2000. Abstracts.
    Antivir Ther; 2000; 5 Suppl 3():1-161. PubMed ID: 10963027
    [No Abstract]   [Full Text] [Related]  

  • 83. Metabolic abnormalities and use of HIV-1 protease inhibitors.
    Martinez E; Gatell J
    Lancet; 1998 Sep; 352(9130):821-2. PubMed ID: 9737319
    [No Abstract]   [Full Text] [Related]  

  • 84. HIV protease and the pathogenesis of AIDS.
    Goldberg B; Stricker RB
    Res Virol; 1996; 147(6):375-9. PubMed ID: 8958590
    [No Abstract]   [Full Text] [Related]  

  • 85. Current and Emerging Drug Targets for Human Immunodeficiency Virus.
    Waheed AA; Tachedjian G
    Curr Top Med Chem; 2016; 16(10):1072-3. PubMed ID: 26381413
    [No Abstract]   [Full Text] [Related]  

  • 86. HIV genotype and phenotype--arresting resistance?
    Flexner C
    JAMA; 2000 May; 283(18):2442-4. PubMed ID: 10815093
    [No Abstract]   [Full Text] [Related]  

  • 87. Protease inhibitors: promising new weapons against HIV.
    Isada CM
    Cleve Clin J Med; 1996; 63(4):204-8. PubMed ID: 8764690
    [No Abstract]   [Full Text] [Related]  

  • 88. Proteinase inhibitors.
    Baboonian C; Dalgleish AG
    Mol Aspects Med; 1991; 12(4):329-40. PubMed ID: 1813774
    [No Abstract]   [Full Text] [Related]  

  • 89. Genetic selection for dissociative inhibitors of designated protein-protein interactions.
    Park SH; Raines RT
    Nat Biotechnol; 2000 Aug; 18(8):847-51. PubMed ID: 10932153
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Drug-resistant HIV shows a worrying increase in the UK.
    Loder N
    Nature; 2000 Sep; 407(6801):120. PubMed ID: 11001026
    [No Abstract]   [Full Text] [Related]  

  • 91. 6-Hydroxy-1,3-dioxin-4-ones as non-peptidic HIV protease inhibitors.
    Lee YS; Lee YS; Lee JY; Kim SN; Lee CK; Park H
    Bioorg Med Chem Lett; 2000 Dec; 10(23):2625-7. PubMed ID: 11128638
    [TBL] [Abstract][Full Text] [Related]  

  • 92. New PI active against many strains.
    AIDS Patient Care STDS; 1999 Sep; 13(9):568. PubMed ID: 10813041
    [No Abstract]   [Full Text] [Related]  

  • 93. Conformational restriction: an effective tactic in 'follow-on'-based drug discovery.
    Fang Z; Song Y; Zhan P; Zhang Q; Liu X
    Future Med Chem; 2014 May; 6(8):885-901. PubMed ID: 24962281
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Recent advances in the design of HIV proteinase inhibitors.
    Martin JA
    Antiviral Res; 1992 Apr; 17(4):265-78. PubMed ID: 1642479
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Incorporating target heterogeneity in drug design.
    Velazquez-Campoy A; Freire E
    J Cell Biochem Suppl; 2001; Suppl 37():82-8. PubMed ID: 11842432
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Predicting the transmission of drug-resistant HIV: comparing theory with data.
    Blower SM; Aschenbach AN; Kahn JO
    Lancet Infect Dis; 2003 Jan; 3(1):10-1. PubMed ID: 12505024
    [No Abstract]   [Full Text] [Related]  

  • 97. Tetrahydrofuran, tetrahydropyran, triazoles and related heterocyclic derivatives as HIV protease inhibitors.
    Ghosh AK; Anderson DD
    Future Med Chem; 2011 Jul; 3(9):1181-97. PubMed ID: 21806380
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Lessons learned fighting HIV can be applied to anti-cancer drug design.
    Gustchina A; Jaskólski M; Wlodawer A
    Cell Cycle; 2006 Mar; 5(5):463-4. PubMed ID: 16479175
    [No Abstract]   [Full Text] [Related]  

  • 99. Rational targets for design and synthesis of anti-HIV agents.
    Pearson ML
    Ann N Y Acad Sci; 1990; 616():86-9. PubMed ID: 1706576
    [No Abstract]   [Full Text] [Related]  

  • 100. Use of HIV suspectibility testing linked to survival. Clear support for GPT.
    AIDS Alert; 2009 Oct; 24(10):114-6. PubMed ID: 20034137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.